EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical Implications of Minipuberty

Anders Juul iD

New England Journal of Medicine · 26.03.2026 · 394 (12) · 1204-1214

DOI: 10.1056/nejmra2305989 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 26.03.2026. Verfasst von Anders Juul. Beteiligte Einrichtung: Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen. Hauptthemen laut MEDLINE: Puberty, Hypothalamic-Pituitary-Gonadal Axis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Minipuberty refers to a specific period in early postnatal life with high activity of the hypothalamic-pituitary-gonadal (HPG) hormone axis. In infant boys 1 to 3 months of age, high concentrations of follicle-stimulating hormone and luteinizing hormone are released, which results in high levels of gonadal hormones from testicular Leydig cells (testosterone and insulin-like 3) and Sertoli cells (inhibin B and antimüllerian hormone). The HPG axis is also active in infant girls, who have adult levels of follicle-stimulating hormone and luteinizing hormone during this period. Immediately after minipuberty, the HPG axis is silenced for approximately 10 years and is reactivated only with the onset of puberty. Thus, minipuberty represents an early window for diagnosing disorders of sexual differentiation and rare endocrine disorders, such as congenital hypogonadotropic hypogonadism, and may help guide dosing of therapeutic interventions including gonadotropin therapy. Of note, minipuberty predicts adult reproductive capacity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PubertyHypothalamic-Pituitary-Gonadal AxisChildFemaleHumansInfantInfant, NewbornMaleFollicle Stimulating HormoneHypogonadismLuteinizing HormoneTestisLeydig CellsSertoli CellsTestosteroneInhibinsAnti-Mullerian HormoneGonadotropinsEarly DiagnosisDisorders of Sex DevelopmentChild, Preschool

Substanzen

Follicle Stimulating HormoneLuteinizing HormoneTestosteroneinhibin BInhibinsAnti-Mullerian HormoneGonadotropins

Autor:innen und Institutionen

  • Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen.
  • Research Center in Endocrine Disruption of Male Reproduction and Child Health, Rigshospitalet and University of Copenhagen, Copenhagen.

ORCID-Profile: Anders Juul

Zitieren

APA

Juul, A. (2026). Clinical Implications of Minipuberty. New England Journal of Medicine, 394(12), 1204-1214. https://doi.org/10.1056/nejmra2305989

Vancouver

Juul A. Clinical Implications of Minipuberty. New England Journal of Medicine. 2026;394(12):1204-1214. doi:10.1056/nejmra2305989

BibTeX
@article{Juul2026,
  author = {Juul, Anders},
  title = {Clinical Implications of Minipuberty},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {12},
  pages = {1204--1214},
  doi = {10.1056/nejmra2305989}
}
Kostenlos starten →